See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy
Publications for Peter Gross
Updated daily
Loading publication list...
| # | PubMedId | Deleted | Publication |
|---|---|---|---|
| 1 | 40086754 | 0 | Douketis JD, Li N, St John M, et al. Perioperative management of direct oral anticoagulants in patients having a high-bleed-risk surgery or neuraxial procedure: the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE)-2 pilot randomized trial. J Thromb Haemost. 2025 Jul;23(7):2226-2234. doi: 10.1016/j.jtha.2025.03.003. Epub 2025 Mar 12. |
| 2 | 39111636 | 0 | Chen J, Lynn EG, Sharma H, et al. Small Molecules Targeting GRP78 Mitigate Anti- GRP78 Autoantibody-Mediated Tissue Factor Procoagulant Activity in Cultured Endothelial Cells. J Thromb Haemost. 2024 Aug 5:S1538-7836(24)00432-X. doi: 10.1016/j.jtha.2024.07.015. |
| 3 | 39002730 | 0 | Schulman S, Bhagirath V, Chan N, et al. Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors. J Thromb Haemost. 2024 Oct;22(10):2761-2766. doi: 10.1016/j.jtha.2024.07.002. Epub 2024 Jul 11. |
| 4 | 38382740 | 0 | Dai Y, Kretz CA, Kim PY, et al. A specific fluorescence resonance energy quenching-based biosensor for measuring thrombin activity in whole blood. J Thromb Haemost. 2024 Jun;22(6):1627-1639. doi: 10.1016/j.jtha.2024.02.007. Epub 2024 Feb 19. |
| 5 | 37910528 | 0 | Shaw JR, James T, Douxfils J, et al. Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature. PLoS One. 2023 Nov 1;18(11):e0293632. doi: 10.1371/journal.pone.0293632. eCollection 2023. |
| 6 | 37907305 | 0 | Makedonov I, Kahn S, Abdulrehman J, et al. TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol. BMJ Open. 2023 Oct 31;13(10):e064715. doi: 10.1136/bmjopen-2022-064715. |
| 7 | 37850360 | 0 | Lun R, Cerasuolo JO, Carrier M, et al. Previous Ischemic Stroke Significantly Alters Stroke Risk in Newly Diagnosed Cancer Patients. Stroke. 2023 Oct 18. doi: 10.1161/STROKEAHA.123.042993. |
| 8 | 37751849 | 0 | Chessum JE, Shaya SA, Rajab D, et al. Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model. J Thromb Haemost. 2023 Sep 24:S1538-7836(23)00718-3. doi: 10.1016/j.jtha.2023.09.016. |
| 9 | 37438219 | 0 | Karkouti K, Gross PL. What can ex vivo experiments contribute to clinical haemostasis management? Br J Anaesth. 2023 Sep;131(3):424-425. doi: 10.1016/j.bja.2023.06.041. Epub 2023 Jul 10. |
| 10 | 37144115 | 0 | Carlin S, Gross PL. Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients. JACC CardioOncol. 2023 Feb 7;5(2):201-202. doi: 10.1016/j.jaccao.2022.12.006. eCollection 2023 Apr. |
, McMaster University